Background <p>The introduction of disease-modifying therapies (DMTs) has transformed the prognosis of children with spinal muscular atrophy (SMA), creating new uncertainties in defining paediatric palliative care (PPC). This study explores the perspectives of paediatric neurologists and paediatric physical medicine and rehabilitation (PM&amp;R) specialists in France on the definition of a palliative care (PC) situation, the PC practices in SMA and the integration of PPC teams in this evolving context.</p> Methods <p>We conducted a qualitative study with 16 French paediatric neurologists and paediatric PM&amp;R specialists. Semi-structured interviews were thematically analysed and supported by reflexive practices and triangulation.</p> Results <p>Five main categories emerged from the analysis, revealing the heterogeneous definition of a PC situation and of the widespread involvement of PPC teams in untreated children. In the case of the treated SMA type 1 children, the PPC teams were mainly not involved, although the clinical complexity and uncertainty were acknowledged, and many of these teams’ qualifications were recognised. This was hindered by several factors, including specialists’ self-perceived expertise, difficulties in distinguishing specific skills from those of other teams, and the challenge of introducing PC to parents. Facilitators included renaming PPC teams, ensuring availability outside office hours, and perceiving PPC professionals as colleagues.</p> Conclusions <p>This study highlights the widespread dimension of the PC dimension in SMA type 0 and 1 and the heterogeneous perceptions of PPC in light of the prognostic uncertainty introduced by DMTs among specialists caring for SMA. Exploring the introduction of a PPC team as a family-centered choice in treated SMA type 1 children could facilitate practitioners’ choice in referring to a PPC team.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Paediatric palliative approach in the era of disease modifying therapies in spinal muscular atrophy — a comprehensive landscape of French specialist physicians’ perspectives

  • Marie-Liesse Guenée,
  • Claire Pilet,
  • Hélène Martinez,
  • Véronique Christophe,
  • Matthias Schell

摘要

Background

The introduction of disease-modifying therapies (DMTs) has transformed the prognosis of children with spinal muscular atrophy (SMA), creating new uncertainties in defining paediatric palliative care (PPC). This study explores the perspectives of paediatric neurologists and paediatric physical medicine and rehabilitation (PM&R) specialists in France on the definition of a palliative care (PC) situation, the PC practices in SMA and the integration of PPC teams in this evolving context.

Methods

We conducted a qualitative study with 16 French paediatric neurologists and paediatric PM&R specialists. Semi-structured interviews were thematically analysed and supported by reflexive practices and triangulation.

Results

Five main categories emerged from the analysis, revealing the heterogeneous definition of a PC situation and of the widespread involvement of PPC teams in untreated children. In the case of the treated SMA type 1 children, the PPC teams were mainly not involved, although the clinical complexity and uncertainty were acknowledged, and many of these teams’ qualifications were recognised. This was hindered by several factors, including specialists’ self-perceived expertise, difficulties in distinguishing specific skills from those of other teams, and the challenge of introducing PC to parents. Facilitators included renaming PPC teams, ensuring availability outside office hours, and perceiving PPC professionals as colleagues.

Conclusions

This study highlights the widespread dimension of the PC dimension in SMA type 0 and 1 and the heterogeneous perceptions of PPC in light of the prognostic uncertainty introduced by DMTs among specialists caring for SMA. Exploring the introduction of a PPC team as a family-centered choice in treated SMA type 1 children could facilitate practitioners’ choice in referring to a PPC team.